219 related articles for article (PubMed ID: 23359100)
1. Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?
Brunnekreef JJ; Hoogervorst P; Ploegmakers MJ; Rijnen WH; Schreurs BW
Int Orthop; 2013 Apr; 37(4):583-7. PubMed ID: 23359100
[TBL] [Abstract][Full Text] [Related]
2. Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac.
Winkler S; Springorum HR; Vaitl T; Handel M; Barta S; Kehl V; Craiovan B; Grifka J
Int Orthop; 2016 Apr; 40(4):673-80. PubMed ID: 26728611
[TBL] [Abstract][Full Text] [Related]
3. Etoricoxib is safe and effective in preventing heterotopic ossification after primary total hip arthroplasty.
Oberberg S; Nottenkämper J; Heukamp M; Krapp J; Willburger RE
J Orthop Surg Res; 2021 Feb; 16(1):163. PubMed ID: 33639986
[TBL] [Abstract][Full Text] [Related]
4. Comment on Brunnekreef et al.: Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?
Zhang H; Guo W; Zhang KN; Lou ZY
Int Orthop; 2013 Aug; 37(8):1629. PubMed ID: 23736968
[No Abstract] [Full Text] [Related]
5. Response to comment on Brunnekreef et al.: Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?
Brunnekreef JJ; Schreurs BW
Int Orthop; 2013 Aug; 37(8):1631. PubMed ID: 23778642
[No Abstract] [Full Text] [Related]
6. Rofecoxib inhibits heterotopic ossification after total hip arthroplasty.
van der Heide HJ; Koorevaar RC; Lemmens JA; van Kampen A; Schreurs BW
Arch Orthop Trauma Surg; 2007 Sep; 127(7):557-61. PubMed ID: 17106714
[TBL] [Abstract][Full Text] [Related]
7. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
[TBL] [Abstract][Full Text] [Related]
8. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
Grohs JG; Schmidt M; Wanivenhaus A
Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
[TBL] [Abstract][Full Text] [Related]
9. Adherence to routine use of pharmacological prophylaxis of heterotopic ossification after total hip arthroplasty: results from an Italian multicenter, prospective, observational survey.
Barbato M; D'Angelo E; Di Loreto G; Menna A; Di Francesco A; Salini V; Zoppi U; Cavasinni L; La Floresta P; Romanò CL
J Orthop Traumatol; 2012 Jun; 13(2):63-7. PubMed ID: 22358779
[TBL] [Abstract][Full Text] [Related]
10. Heterotopic ossification after surface replacement arthroplasty and total hip arthroplasty: a randomized study.
Rama KR; Vendittoli PA; Ganapathi M; Borgmann R; Roy A; Lavigne M
J Arthroplasty; 2009 Feb; 24(2):256-62. PubMed ID: 18534415
[TBL] [Abstract][Full Text] [Related]
11. Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery.
Rath E; Warschawski Y; Maman E; Dolkart O; Sharfman ZT; Salai M; Amar E
Am J Sports Med; 2016 Mar; 44(3):677-81. PubMed ID: 26695395
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of heterotopic ossification in cemented versus noncemented total hip joint replacement in patients with osteoarthrosis: a randomized clinical trial.
Nayak KN; Mulliken B; Rorabeck CH; Bourne RB; Woolfrey MR
Can J Surg; 1997 Oct; 40(5):368-74. PubMed ID: 9336527
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial.
Saudan M; Saudan P; Perneger T; Riand N; Keller A; Hoffmeyer P
J Bone Joint Surg Br; 2007 Feb; 89(2):155-9. PubMed ID: 17322426
[TBL] [Abstract][Full Text] [Related]
14. Heterotopic ossification after total hip arthroplasty: When is development completed?
Willburger RE; Brinkhoff F; Nottenkämper J; Krapp J; Oberberg S
J Orthop Surg Res; 2022 Mar; 17(1):147. PubMed ID: 35248082
[TBL] [Abstract][Full Text] [Related]
15. Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis.
Zhu XT; Chen L; Lin JH
Medicine (Baltimore); 2018 Aug; 97(31):e11649. PubMed ID: 30075549
[TBL] [Abstract][Full Text] [Related]
16. [Incidence of anterior intertrochanteric ossifications after total hip arthroplasty--a retrospective long-term follow-up study].
Metzner G; Lindner B; Neumann D; Dorn U
Z Orthop Unfall; 2010 Mar; 148(2):174-9. PubMed ID: 20178081
[TBL] [Abstract][Full Text] [Related]
17. Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials.
Xue D; Zheng Q; Li H; Qian S; Zhang B; Pan Z
Int Orthop; 2011 Jan; 35(1):3-8. PubMed ID: 19830425
[TBL] [Abstract][Full Text] [Related]
18. Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy.
Seegenschmiedt MH; Keilholz L; Martus P; Goldmann A; Wölfel R; Henning F; Sauer R
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):161-71. PubMed ID: 9300751
[TBL] [Abstract][Full Text] [Related]
19. Heterotopic bone formation in total hip arthroplasty: predisposing factors, classification and the significance for clinical outcome.
Schara K; Herman S
Acta Chir Orthop Traumatol Cech; 2001; 68(2):105-8. PubMed ID: 11706718
[TBL] [Abstract][Full Text] [Related]
20. Heterotopic ossification after total hip arthroplasty: risk factors and prevention.
Vastel L; Kerboull L; Anract P; Kerboull M
Rev Rhum Engl Ed; 1998 Apr; 65(4):238-44. PubMed ID: 9599792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
